Burçin Keçeci

Burçin Keçeci

Auto-generated profile, based on publicly available information

Burçin Keçeci

Private Practice, Izmir, Turkiye

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Turkish Journal of Pathology
Verified
Journal Article
Open access
BDBasak Doganavsargil
Basak Doganavsargil
EAEzgi Ayhan
Ezgi Ayhan
MAMehmet Argin
Mehmet Argin
BPBurcin Pehlivanoglu
Burcin Pehlivanoglu
BKBurcin Kececi
Burcin Kececi
FOFikri Oztop
Fikri Oztop
Bone cysts are benign lesions occurring in any bone, regardless of age. They are often asymptomatic but may cause pain, swelling, fractures, and local recurrence and may be confused with other bone lesions. We retrospectively re-evaluated 143 patients diagnosed with aneurysmal bone cyst (n=98, 68.5%), solitary bone cysts (n=17 11.9%), pseudocyst (n=10.7%), intraosseous ganglion (n=3, 2.1%), hydatid cyst (n=2; 1.4), epidermoid cyst (n=1, 0.7%) and cysts demonstrating "mixed" aneurysmal-solitary bone cyst histology (n=12, 8.4%), and compared them with nonparametric tests. Aneurysmal bone cyst, solitary bone cysts and mixed cysts were frequently seen in the first two decades of life while the others occurred after the fourth decade. Aneurysmal bone cysts, intraosseous ganglion and pseudocysts were more common in women contrary to solitary bone cyst and mixed cysts (the female/male ratio was 1.22, 2 and 1.5 versus 0.7 and 0.5, respectively). Aneurysmal bone cyst, solitary bone cysts and "mixed" cysts were mostly seen in long bones, predominantly the femur, while epidermoid, hydatid and pseudocysts were all seen in flat bones like the vertebra, pelvis and mandible (p=0.001, chi-square). Repeat biopsies were performed in 19 cases (13.3%), 84.2% of which were aneurysmal bone cyst (5 conventional, 9 solid, 1 secondary and 1 subperiosteal) and three (15.8%) were mixed cysts (p=0.02, chi-square). Notably, some of them were located in inaccessible areas of pelvis (n=3), femur (n=3) and maxilla (n=2). The most common and challenging intraosseous cysts are aneurysmal bone cysts, particularly the "solid" variant. The "mixed" aneurysmal-solitary bone cyst "subgroup" requires further research with larger series to be defined more thoroughly.

1 January 2020 in Acta Orthopaedica et Traumatologica Turcica
Verified
Journal Article
Open access
IKİsMail Eralp Kaçmaz
İsMail Eralp Kaçmaz
BKBurçin Keçeci
Burçin Keçeci
CBCan Doruk Basa
Can Doruk Basa
DSDündar Sabah
Dündar Sabah
Objective: The aim of this study was to compare the results of chemotherapy or combined chemotherapy-radiation therapy with surgical intervention following neodjuvant therapy in pelvic Ewing’s sarcoma patients. Methods: The study population consisted of 39 patients with pelvic Ewing’s sarcoma treated in our clinic between 1994 and 2014. Of these patients, 28 patients (11 boys and 17 girls; mean age: 19.57±6.8 years) were treated with chemotherapy and radiation therapy and the remaining 11 patients (9 boys and 2 girls; mean age: 18.64±8.1 years) patients underwent surgical intervention after neoadjuvant chemotherapy or chemotherapy plus radiation therapy. Internal hemipelvectomy was performed in 10 patients, and external hemipelvectomy was performed in one patient. Survival rates were compared between the surgical and non-surgical treatment groups. Predictive factors, such as treatment protocol (surgery, neoadjuvant chemotherapy, definitive radiotherapy), mass localisation, mass size, presence of metastasis at the time of diagnosis, and presence of late metastases were compared between the groups. The effects of each variable on survival were also examined. Results: The overall 3- and 5-year survival rates of the 28 non-surgical patients were 41.4% and 26.1%, respectively, while those of the surgical patients were 53% and 35.4%, respectively (p=0.777). Large mass size, presence of metastasis at the time of diagnosis, and presence of late metastases were significantly associated with lower survival rates. Conclusion: The survival rates of the patients who underwent surgery were higher than those of non-surgical patients, although the difference was not statistically significant. Definitive radiation and chemotherapy would be preferable in selected cases, such as patients with sacral localisation, without surgical intervention. Level of Evidence: Level III, Therapeutic Study Cite this article as: Kaçmaz İE, Keçeci B, Basa CD, Sabah D. Treatment of pelvic Ewing’s sarcoma: Pros and cons of chemotherapy plus definitive radiotherapy versus surgery. Acta Orthop Traumatol Turc 2020; 54(1): 42-8.

19 November 2025 in Acta Orthopaedica et Traumatologica Turcica
Verified
Journal Article
Open access
PDF file
HKHüseyin Kaya
Hüseyin Kaya
AVArman Vahabi
Arman Vahabi
ADAli Engin Daştan
Ali Engin Daştan
TÇTahsin Sami Çolak
Tahsin Sami Çolak
BKBurçin Keçeci
Burçin Keçeci
DSDündar Sabah
Dündar Sabah
Objective: Total femoral replacements for oncological indications are a rare indication, and there is limited data on functional outcomes, complications, and implant survival rates. The purpose of this study was to investigate functional outcomes, the rate and nature of com plications associated with this technique, and the survival rates of the implant used. Methods: This is a retrospective case series from a single subspeciality orthopedic oncology unit in an urban referral center that evalu ated patients treated between January 2000 and May 2023. A total of 27 patients were included in the final analyses. The Musculoskeletal Tumor Society (MSTS) scoring system was used for functional evaluation. The received adjuvant-neoadjuvant chemotherapies and radio therapies, resected soft tissues during index surgery, complications, the number and extent of secondary surgical interventions, and data on local recurrence were recorded through chart review. Data on implant loss for any reason was also recorded. Complication-freesurvival rate and implant-loss-free survival rate were calculated using the Kaplan–Meier estimator at 60 months. The Henderson clas sification system was used to categorize failure modes. Results: The median MSTS score at the most recent follow-up was 21 (range: 17-23). A total of 16 complications occurred in 13 patients. Only one of these complications was an intraoperative issue. Ten of the 16 complications necessitated one or more secondary surgical interventions. The most common complication was infection, occurring in 8 patients. Other complications included hip pain that neces sitated total hip arthroplasty, leg-length discrepancy, and spontaneous patella fractures, each occurring in 2 patients. At 60 months, 10 patients (37%) experienced complications. The mean estimated complication-free survival was 39 months (95% CI: 29-49). There were 6 patients in total who experienced implant loss. Infection was the sole cause of implant loss in 4 patients. Implant loss occurred in 1 patient due to recurrence and in another patient due to a combination of recurrence and infection, which led to amputation in both cases. The mean estimated implant-loss-free survival was 50 months (95% CI: 42-58). Conclusion: Total femoral replacement is reserved for distinctly specific oncological indications, where other more biological reconstruc tion methods are not feasible. This technique could yield satisfactory functional outcomes, along with a favorable implant survival rate and complication-free survival rate at mid-term. Infection remains the most common complication associated with this technique, while the main causes of implant failure are infection and local recurrence. Future studies focusing on strategies to prevent such complications and define clearer patient selection criteria may substantially improve the overall success of this technique. Cite this article as: Kaya H, Vahabi A, Daştan AE, Çolak TS, Keçeci B, Sabah D. Total femoral replacement for oncologic indications: Functional outcomes, complications, and implant survival rates. Acta Orthop Traumatol Turc., 2025;59(6):477-484.

31 December 2019 in Ege Tıp Dergisi
Verified
Journal Article
Open access
HKHüseyin Kaya
Hüseyin Kaya
DSDündar Sabah
Dündar Sabah
BKBurcin Keçeci̇
Burcin Keçeci̇
BDBaşak DOĞANAVŞARGİL
Başak DOĞANAVŞARGİL
MSMurat Sezak
Murat Sezak
MKMehmet Kantar
Mehmet Kantar
Amaç: Ege Üniversitesi Hastanesinde 1992-2017 arası kanser tanı ve tedavisi yapılan 3179 kemik ve yumuşak doku sarkomunun epidemiyolojik ve sağ kalım özelliklerinin analizi ve sonuçların kaynaklarla karşılaştırılmasıdır. Gereç ve Yöntem: Ege Üniversitesi Kanserle Savaş Araştırma ve Uygulama Merkezi tarafından toplanan kemik ve yumuşak doku sarkomu verileri CANREG özel bilgisayar programına kayıt edilmiş, DSÖ ve SEER sistemleri temelinde gruplanarak analizler yapılmıştır. İstatistik analizlerde Ki-kare, General Linear Model, Kaplan Meier sağ kalım analizleri uygulanmıştır. Kaplan Meier sağ kalım analizinde Log Rank (Mantel-Cox), Breslow (Generalized Wilcoxon) ve Tarone-Ware istatistikleri kullanılmıştır. İstatistik analizlerde p